Should low-risk DCIS lose the cancer label? An evidence review Tara MaCaitlin R. SemsarianKaty J. L. Bell Review Open access 19 April 2023 Pages: 415 - 433
Malignant phyllodes tumors of the breast: the malignancy grading and associations with prognosis Junjun LiuFangfang LiHong Lu Preclinical study 18 April 2023 Pages: 435 - 444
Management of the axilla in postmenopausal patients with cN0 hormone receptor-positive/HER2-negative breast cancer treated with neoadjuvant endocrine therapy and its prognostic impact Amparo Garcia-TejedorCatalina FaloSonia Pernas Clinical trial 12 April 2023 Pages: 445 - 456
A phase II study of neoadjuvant atezolizumab and nab-paclitaxel in patients with anthracycline-resistant early-stage triple-negative breast cancer Clinton YamElizabeth A. MittendorfJennifer K. Litton Clinical trial 15 April 2023 Pages: 457 - 469
Tamoxifen pharmacokinetics and pharmacodynamics in older patients with non-metastatic breast cancer E. T. D. SouwerA. Sanchez-SpitmanT. van Gelder Clinical trial Open access 17 April 2023 Pages: 471 - 478
Subjective social status, race, and metabolic syndrome in women with breast cancer Giampaolo GrecoNina A. BickellEmily J. Gallagher Clinical trial 23 April 2023 Pages: 479 - 487
Use of imaging prediction model for omission of axillary surgery in early-stage breast cancer patients Soo-Yeon KimYunhee ChoiJung Min Chang Clinical trial 25 April 2023 Pages: 489 - 499
Feasibility of introducing a smartphone navigation application into the care of breast cancer patients (The FIONA Study) Steven J. IsakoffMaya R. SaidJeffrey M. Peppercorn Clinical trial Open access 27 April 2023 Pages: 501 - 509
Racial/ethnic and socioeconomic differences in breast cancer surgery performed and delayed treatment: mediating impact on mortality Pierre FweloKenechukwu O. S. NwosuAyrton Bangolo Epidemiology 13 April 2023 Pages: 511 - 531
Associations between health-related fitness and quality of life in newly diagnosed breast cancer patients Kerry S. CourneyaKi-Yong AnChristine M. Friedenreich Epidemiology 14 April 2023 Pages: 533 - 544
Association between gout and subsequent breast cancer: a retrospective cohort study including 67,598 primary care patients in Germany Niklas GremkeSebastian GriewingMatthias Kalder Epidemiology Open access 18 April 2023 Pages: 545 - 552
Patient reported symptom burden amongst immigrant and Canadian long-term resident women undergoing breast cancer surgery Elena ParvezMegan ChuJessica Bogach Epidemiology 21 April 2023 Pages: 553 - 563
Differences in survivorship care experiences among older breast cancer survivors by clinical cancer characteristics, race/ethnicity, and socioeconomic factors: A SEER-CAHPS study Kate E. DibbleZhengyi DengAvonne E. Connor Epidemiology 24 April 2023 Pages: 565 - 582
Comments on: a prediction model for distant metastasis after isolated locoregional recurrence of breast cancer Fei-Lin QuJun-Jie LiZhi-Ming Shao Letter to the Editor 10 April 2023 Pages: 583 - 584
Earliest depiction of unilateral gynecomastia in history 300–250 B.C Hutan Ashrafian Letter to the Editor 15 April 2023 Pages: 585 - 586
Letter to the editor regarding the article “pregnancy-associated breast cancer: a multicenter study comparing clinicopathological factors, diagnosis, and treatment outcomes with non-pregnant patients” Elham SajjadiKonstantinos VenetisNicola Fusco Letter to the Editor 19 April 2023 Pages: 587 - 588
High expression of the RET receptor tyrosine kinase and its ligand GDNF identifies a high-risk subset of estrogen receptor positive breast cancer Rasha T. KakatiHyunsoo KimPhilip M. Spanheimer Original Laboratory Investigation 15 April 2023 Pages: 589 - 601
Identification of genetic and immune signatures for the recurrence of HER2-positive breast cancer after trastuzumab-based treatment Chi XuYahui WangZhiyong Liang Original Laboratory Investigation 21 April 2023 Pages: 603 - 615
The association between age at breast cancer diagnosis and prevalence of pathogenic variants Mary B. DalyEric RosenthalAllison W. Kurian Original Laboratory Investigation Open access 21 April 2023 Pages: 617 - 626
Correction to: Genetic ablation of pregnancy zone protein promotes breast cancer progression by activating TGF-β/SMAD signaling Rohit KumarEkaterina KuliginaSyed K. Hasan Correction 20 April 2023 Pages: 627 - 629